DIVERSYS APPOINTS PAMELA HAY AS CHIEF COMMERCIAL OFFICER Former Senior Vice President of Dyax Joins Diversys Cambridge, UK and Cambridge, USA, October 11, 2001 ... Diversys Limited, the protein engineering company, today announced that the prominent business development executive Pamela Hay has joined the company as Chief Commercial Officer.Ms Hay
is considered an expert in the developing business opportunities in the fields of protein repertoires and protein engineering.She
is also one of the more prolific negotiators of deals in this sector.
has over 15 years of legal and business development experience with major biotechnology and pharmaceutical companies.With a degree in biology from Cornell and a law degree from the University of Wisconsin, Ms Hay worked for 5 years with Biogen as Corporate Counsel, where her responsibilities included managing the Company's patent estate and negotiation of business transactions.Ms Hay
negotiated deals with SmithKline Beecham
, Abbott Laboratories
and with Merck
hepatitis B patent estate.Ms Hay moved on to become General Counsel for T Cell Sciences, now Avant Immunotherapeutics, where she led the Company's legal and intellectual property activities. Ms Hay joined Dyax Corp. in 1996, where she rose to become Senior Vice President of Corporate Development and Strategic Opportunities.
, Ms Hay
team negotiated over 75 collaboration, technology transfer and license agreements involving the Company's phage display technology and product leads, managed the Company's growing patent portfolio and legal needs, and helped lead the acquisition of new technologies. Ms Hay will assume responsibility for the commercialisation of Diversys' protein repertoire and engineering technologies for therapeutic, diagnostic and research use.In addition, she will be in charge of business development activities and management of Diversys intellectual property portfolio.Ms Hay
will be based in Diversys'
new commercial office in Cambridge, Massachusetts in the USA.